[Clinical trials in Germany and in the EU in the new legislative environment. An analysis from the industry's point of view].
Heidenreich, K
[Clinical trials in Germany and in the EU in the new legislative environment. An analysis from the industry's point of view]. [electronic resource] - Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz Apr 2005 - 415-22 p. digital
Publication Type: English Abstract; Journal Article
1436-9990
10.1007/s00103-005-1015-8 doi
Clinical Trials as Topic--legislation & jurisprudence
Drug Approval--legislation & jurisprudence
Drug-Related Side Effects and Adverse Reactions
European Union
Germany
Guidelines as Topic
Humans
Multicenter Studies as Topic
Quality Assurance, Health Care--legislation & jurisprudence
[Clinical trials in Germany and in the EU in the new legislative environment. An analysis from the industry's point of view]. [electronic resource] - Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz Apr 2005 - 415-22 p. digital
Publication Type: English Abstract; Journal Article
1436-9990
10.1007/s00103-005-1015-8 doi
Clinical Trials as Topic--legislation & jurisprudence
Drug Approval--legislation & jurisprudence
Drug-Related Side Effects and Adverse Reactions
European Union
Germany
Guidelines as Topic
Humans
Multicenter Studies as Topic
Quality Assurance, Health Care--legislation & jurisprudence